Doximity DOCS
Price chart
Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.
DOCS at a glance
DOCS last changed hands at $28.73 (down 2.97%). At $5.13B, Doximity is ranked #2029 by size among the 3753 stocks on BeStock.
The 52-week range is $17.15 to $51.85. Today's price is about 33% of the way from the low to the high. Holders are behind 43.0% over twelve months, but up 13.6% across the last three months.
Price is below the 50-day average ($30.29) but above the 200-day ($25.07); RSI is 35, and the last 30 sessions moved at roughly 43% annualized volatility.
For the quarter ended Sep 2026 it reported $174.54M in revenue, up 3.6% from a year earlier, with $34.73M of net profit (a 21.1% margin).
Valuation works out to 39.9 times trailing earnings, 18% below its five-year average of 48.8. The median for its industry group is 35.3.
10 analysts follow the stock and the average call is "hold". The mean target, $29.88, sits 4.0% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Key statistics
Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
BeStock Grade
Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
10 analysts, consensus Hold.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
Six-factor research snapshot
Overall percentile: 71.1 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.
| Factor | Percentile |
|---|---|
| Valuation | 10.8 |
| Growth | 82.0 |
| Profitability | 96.6 |
| Momentum | 53.9 |
| Financial health | 96.9 |
| Analyst view | 9.6 |
Price forecast
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $29.88, 4.0% above today’s price, with a consensus rating of Hold. Morningstar’s fair value model puts the stock at $42.97, so shares trade 33.1% below that estimate. On earnings multiple, it sits in the 47th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Performance
Price return over each window, from adjusted daily and weekly closes
Technical signals
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -11.7% | Bearish |
| Price vs 50-day average | -5.1% | Bearish |
| Price vs 200-day average | +14.6% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 34.7 | Bearish |
| MACD (12,26,9) | -0.12 | Bearish |
| Bollinger band position | -15% | Neutral |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
How DOCS ranks on BeStock
Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 39.9x earnings, DOCS looks expensive against the market, and trades 13% above the 35.3x median among AI medical concept stocks names. The two comparisons do not always agree.
BeStock Momentum
DOCS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.
Strategy Backtest
Pick a strategy above and run the backtest to see its simulated performance on DOCS.
Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.
Community Sentiment on DOCS
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
DOCS stock: common questions
What is DOCS's latest share price?
$28.73 is the latest print for DOCS, a move of -2.97% against yesterday's close of $29.61. Today's low and high so far: $28.55 and $29.86.
How big is Doximity?
Equity value comes to $5.13B at the current price. By that measure it is number 2029 of the 3753 names in our coverage.
Is DOCS expensive on earnings?
Buyers pay 39.9 times the last twelve months of profit (EPS $0.98). Averaged over five years the multiple has been 48.8, and today's level ranks in the 47th percentile of its own history.
Is DOCS near its 52-week high or low?
The year's floor is $17.15 and the ceiling $51.85. Shares are 44.6% away from that ceiling.
Does Doximity pay a dividend?
Our data shows no dividend paid by Doximity over the trailing twelve months.
Is DOCS rated a buy by Wall Street?
Of 10 analysts, 40% say buy, 40% hold and 20% sell. Price targets average $29.88, with the most cautious at $18.00 and the most optimistic at $40.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on DOCS.
Sign in to join the discussion.